Ardsley Advisory Partners LP T2 Biosystems, Inc. Transaction History

Ardsley Advisory Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$0.58 - $3.01 $507,499 - $2.63 Million	-875,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$1.47 - $3.16 $73,500 - $158,000	50,000 Added 6.06%	875,000 $1.47 Million
Q1 2019 May 15, 2019	BUY	$2.56 - $4.48 $296,704 - $519,232	115,900 Added 16.34%	825,000 $2.17 Million
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $673,182 - $1.55 Million	-225,900 Reduced 24.16%	709,100 $2.13 Million
Q3 2018 Nov 14, 2018	BUY	$5.36 - $7.83 $964,800 - $1.41 Million	180,000 Added 23.84%	935,000 $6.97 Million
Q2 2018 Aug 14, 2018	BUY	$5.97 - $9.58 $4.51 Million - $7.23 Million	755,000 New	755,000 $5.84 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.